Women with advanced cervical cancer -- the most common cancer afflicting young women -- are to get the first officially approved new treatment for
Patients will have access via the Cancer Drugs Fund -LRB- CDF -RRB- until it is considered for routine NHS use
Each year an estimated 600 women with advanced cervical cancer could benefit from Avastin
The drug 's use was accelerated by the US Food and Drug Administration which approved Avastin plus chemotherapy for advanced cervical cancer in August 2014
